White House Delays Abortion Pill Restrictions to Avoid Election Fallout

White House Chief of Staff Susie Wiles has reportedly intervened to limit the political fallout of new restrictions on medication abortion, a method accounting for nearly two-thirds of all abortions in the US. Despite Attorney General Todd Blanche’s stated desire to review nationwide shipping rules and his reported assurances to faith leaders that he would work to ban abortion in every state, the administration is prioritizing electoral optics. Senior officials warned that aggressive moves against the drug could further damage Republican prospects in November, a claim the White House has denied as "completely false."

The Comstock Act and Future Strategy

Beyond immediate electoral concerns, the administration is laying the groundwork for future restrictions. Health and Human Services Secretary Robert F. Kennedy Jr. is spearheading an FDA "safety" review of mifepristone that could tighten prescription rules. Meanwhile, Blanche has signaled openness to reviving the 1873 Comstock Act—a Victorian-era statute that could serve as a "nuclear option" to effectively ban abortion nationwide without congressional approval. While the Biden-era DOJ previously concluded the law does not prohibit mailing abortion drugs unless intended for illegal use, Blanche has vowed to revisit that opinion. Anti-abortion groups, including Students for Life of America, remain in contact with the DOJ, reportedly being told that major policy changes are being held until the ballots are counted.